Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Sep;89(3):402–406. doi: 10.1111/j.1365-2249.1992.tb06970.x

The pattern of mycobacterial antigen recognition in sera from Mantoux-negative individuals is essentially unaffected by bacille Calmette-Guérin (BCG) vaccination in either south India or London.

S Das 1, S H Cheng 1, D B Lowrie 1, K B Walker 1, D A Mitchison 1, R S Vallishayee 1, P R Narayanan 1
PMCID: PMC1554480  PMID: 1516256

Abstract

Paired sera were obtained before and 8 weeks after routine BCG vaccination from 20 PPD-S Mantoux-negative individuals who were living adjacent to the Chingleput BCG vaccine trial area in Tamil Nadu and from seven Mantoux-negative school-children in London, UK. Most subjects became Mantoux-positive after vaccination. In ELISA tests against soluble extracts of BCG or Mycobacterium tuberculosis H37Rv or against PPD-S, pre-vaccination antibody titres of South Indian subjects were about twice those of British subjects but there was no increase in titre of antibodies after vaccination of either population. Western blotting showed that even before vaccination, and even in British subjects, antibodies were present that recognized numerous antigenic components in extracts of BCG and M. tuberculosis. There was no consistent difference between band patterns with South Indian and British subjects and any effect of vaccination on the patterns was minimal.

Full text

PDF
406

Images in this article

404Fig. 2
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardana E. J., Jr, McClatchy J. K., Farr R. S., Minden P. Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol. 1973 Jan;13(1):65–77. [PMC free article] [PubMed] [Google Scholar]
  2. Cheng S. H., Walker L., Poole J., Aber V. R., Walker K. B., Mitchison D. A., Lowrie D. B. Demonstration of increased anti-mycobacterial activity in peripheral blood monocytes after BCG vaccination in British school children. Clin Exp Immunol. 1988 Oct;74(1):20–25. [PMC free article] [PubMed] [Google Scholar]
  3. Daniel T. M., Debanne S. M. The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis. 1987 May;135(5):1137–1151. doi: 10.1164/arrd.1987.135.5.1137. [DOI] [PubMed] [Google Scholar]
  4. Das S., Narayanan S., Paramasivan C. N., Lowrie D. B., Narayanan P. R. Human tuberculosis sera show prominent antibody responses to particulate fractions of Mycobacterium tuberculosis. J Clin Immunol. 1991 Mar;11(2):74–77. doi: 10.1007/BF00917743. [DOI] [PubMed] [Google Scholar]
  5. FUSILLO M. H., WEISS D. L. Lack of circulating antibodies after BCG immunization as assayed by the globulin titration technique. Am Rev Tuberc. 1958 Nov;78(5):793–793. doi: 10.1164/artpd.1958.78.5.793. [DOI] [PubMed] [Google Scholar]
  6. Grange J. M. The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness. Adv Tuberc Res. 1984;21:1–78. [PubMed] [Google Scholar]
  7. Kalish S. B., Radin R. C., Phair J. P., Levitz D., Zeiss C. R., Metzger E. Use of an enzyme-linked immunosorbent assay technique in the differential diagnosis of active pulmonary tuberculosis in humans. J Infect Dis. 1983 Mar;147(3):523–530. doi: 10.1093/infdis/147.3.523. [DOI] [PubMed] [Google Scholar]
  8. Krambovitis E. Detection of antibodies to Mycobacterium tuberculosis plasma membrane antigen by enzyme-linked immunosorbent assay. J Med Microbiol. 1986 May;21(3):257–264. doi: 10.1099/00222615-21-3-257. [DOI] [PubMed] [Google Scholar]
  9. LAGERCRANTZ R., PETERSON J. C., LIND J. Further studies of tuberculin hemagglutination in tuberculous infection, benign and virulent. Acta Paediatr. 1953 Mar;42(2):113–125. doi: 10.1111/j.1651-2227.1953.tb05573.x. [DOI] [PubMed] [Google Scholar]
  10. Mauch H., Brehmer W. Mycobacterial antibodies after tuberculin testing, BCG- vaccination, BCG-immunotherapy and against cross-reacting antigens in a solid-phase radioimmunoassay. Zentralbl Bakteriol Mikrobiol Hyg A. 1982 Mar;251(3):380–388. [PubMed] [Google Scholar]
  11. Parish C. R. The relationship between humoral and cell-mediated immunity. Transplant Rev. 1972;13:35–66. doi: 10.1111/j.1600-065x.1972.tb00059.x. [DOI] [PubMed] [Google Scholar]
  12. Sutherland I., Springett V. H. Effectiveness of BCG vaccination in England and Wales in 1983. Tubercle. 1987 Jun;68(2):81–92. doi: 10.1016/0041-3879(87)90023-7. [DOI] [PubMed] [Google Scholar]
  13. Turneer M., Van Vooren J. P., Nyabenda J., Legros F., Lecomte A., Thiriaux J., Serruys E., Yernault J. C. The humoral immune response after BCG vaccination in humans: consequences for the serodiagnosis of tuberculosis. Eur Respir J. 1988 Jul;1(7):589–593. [PubMed] [Google Scholar]
  14. Zureck A. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy. J Hyg Epidemiol Microbiol Immunol. 1975;19(4):436–443. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES